Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: Objective It is assumed that the toxic effects of glucose play a role in the outcome of critically ill patients. We studied the impact of the amount of infused glucose as a determinant of mortality. Design A retrospective cohort study design was used as blood glucose levels in critically ill patients are nowadays tightly controlled. Patients Long‐stay critically ill patients (7–30 days). Measurements The association between the mean amount of glucose infusion and both intensive care unit (ICU) and hospital mortality was determined. We corrected for the mean glucose serum concentration, the mean dosage of insulin and for severity of illness, using the acute physiology and chronic health evaluation (APACHE II) score. Results Of the 2042 admitted patients, 273 met the inclusion criteria. The mean length of stay was 14·4 days [interquartile range (IQR) 9–18]. Hospital mortality was significantly lower for patients with a mean glucose level below 8 mmol/l (30/79; 38%) compared to patients with a level above 8 mmol/l (104/194; 54%, P = 0·023). Logistic stepwise multivariate regression analysis for both ICU and hospital mortality as dependent variables showed that APACHE II score and the mean daily amount of infused glucose were associated with mortality. Conclusion In long‐stay ICU patients without blood glucose level control, the ICU and hospital mortality was independently related to the mean amount of infused glucose. In addition, mortality in patients with a mean glucose level above 8·0 mmol/l was higher. Both these determinants of mortality can exert their effects by insulin‐independent uptake of glucose with subsequent toxic intracellular effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170
Cited by
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
“Similarly, the average dose of insulin was lower, reflecting the marked hyperglycaemic effect of parenteral glucose [26, 27].”
BackgroundResultStress hyperglycemia: an essential survival response!
Marik, P. E., & Bellomo, R. (2013) · Critical Care · doi:10.1186/cc12514 · Cited by 729
Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units
Van den Berghe, G., Wilmer, A., Milants, I., Wouters, P. J., Bouckaert, B., Bruyninckx, F., Bouillon, R., & Schetz, M. (2006) · Diabetes · doi:10.2337/db06-0855 · Cited by 599
Toward Understanding Tight Glycemic Control in the ICU
Marik, P. E., & Preiser, J.-C. (2010) · Chest · doi:10.1378/chest.09-1737 · Cited by 365
Metadata
- Authors
- van Der Voort, P. H. J., Feenstra, R. A., Bakker, A. J., de Heide, L., Boerma, E. C., & van Der Horst, I. C. C.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2006-01-04
- Volume
- 64
- Issue
- 2
- Pages
- 141-145
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2027002476
- Cited by
- 72
- References
- 3
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.